108937 ⎘
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes; Hydrolases (3) acting on ester bonds (3.1) Ribonucleases RNAses, DNAses
METHODS OF RECOMBINANT ANTIBODY PRODUCTION AND RELATED CELL SYSTEMS
#2102GENE EDITING
#2103Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA
#2104USE OF AMINOQUINOLINE COMPOUNDS FOR HIGHER GENE INTEGRATION
#2105NUCLEASE AND APPLICATION THEREOF
#2106ENGINEERED GUIDE RNA FOR OPTIMIZED CRISPR/CAS12F1 (CAS14A1) SYSTEM AND USE THEREOF
#2107ENGINEERED REPRODUCTIVE ISOLATION IN ANIMALS
#2108CRISPR-MEDIATED HUMAN GENOME EDITING WITH VECTORS
#2109METHODS AND COMPOSITIONS FOR TREATMENT OF A GENETIC CONDITION
#2110METHODS AND COMPOSITIONS FOR MODIFYING SHADE AVOIDANCE IN PLANTS
#2111METHODS AND COMPOSITIONS FOR MODIFYING ROOT ARCHITECTURE AND/OR IMPROVING PLANT YIELD TRAITS
#2112APPLICATION OF HELZ2 IN DRUGS FOR PREVENTING AND TREATING TUMORS
#2113SAFE HARBOR LOCI
#2114GUIDE RNA WITH CHEMICAL MODIFICATIONS
#2115COMPOSITIONS COMPRISING AN RNA GUIDE TARGETING BCL11A AND USES THEREOF
#2116Gene knockout of variant NRF2 for treatment of cancer
#2117CRISPR/CAS DROPOUT SCREENING PLATFORM TO REVEAL GENETIC VULNERABILITIES ASSOCIATED WITH TAU AGGREGATION
#2118SYSTEMS FOR GENE EDITING AND METHODS OF USE THEREOF
#2119APPLICATION OF SUBSTANCE THAT REDUCES THE CONTENT OR ACTIVITY OF KAT7 IN PREVENTING SENESCENCE AND TREATING HEPATIC FIBROSIS
#2120RATIONALLY-DESIGNED SINGLE-CHAIN MEGANUCLEASES WITH NON-PALINDROMIC RECOGNITION SEQUENCES
#2121ENGINEERED AND CHIMERIC NUCLEASES
#2122FOKI NUCLEASE DOMAIN MUTANT
#2123Novel Variants of Endonuclease V and Uses Thereof
#2124LONG-ACTING DNASE
#2125Dnase Variants
#2126COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING DISEASES OR DISORDERS CAUSED BY OR ASSOCIATED WITH DNASE1 AND/OR DNASE1L3 DEFICIENCY
#2127CHIMERIC PROTEINS AND METHODS OF IMMUNOTHERAPY
#2128Inducible, tunable, and multiplex human gene regulation using CRISPR-Cpf1
#2129GENE KNOCK-OUT FOR TREATMENT OF GLAUCOMA
#2130METHODS AND COMPOSITIONS RELATING TO GENETICALLY ENGINEERED CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS
#2131Compositions and Methods for Treatment of DM1 with SLUCAS9 and SACAS9
#2132CRISPR/CAS SCREENING SYSTEM MATERIALS AND METHODS
#2133TARGETED SEQUENCE ADDITION
#2134COMPOSITIONS COMPRISING AN RNA GUIDE TARGETING PDCD1 AND USES THEREOF
#2135CRISPR systems with engineered dual guide nucleic acids
#2136Using Truncated Guide RNAs (tru-gRNAs) to Increase Specificity for RNA-Guided Genome Editing
#2137TRANSFERABLE TYPE I-F CRISPR-CAS GENOME EDITING SYSTEM
#2138CRISPR RIBONUCLEOPROTEIN COMPLEX GENOME EDITING OF HUMAN INNATE IMMUNE CELLS
#2139METHODS AND COMPOSITIONS FOR GENOME MODIFICATION
#2140PROTECTING OLIGONUCLEOTIDES FOR CRISPR GUIDE RNA
#2141SYSTEMS AND METHODS FOR TREATING CONDITIONS AND DISEASES USING ALTERNATING ELECTRIC FIELDS AND CRISPR-CAS SYSTEM
#2142NOVEL CRISPR-ASSOCIATED SYSTEMS AND COMPONENTS
#2143PROGRAMMABLE GENE EDITING USING GUIDE RNA PAIR
#2144CRISPR/CAS9 TARGETED EXCISION OF THE INTRONIC CTG18.1 TRINUCLEOTIDE REPEAT EXPANSION OF TCF4 AS A THERAPY IN FUCHS' ENDOTHELIAL CORNEAL DYSTROPHY
#2145COMPOSITIONS AND METHODS FOR CAS9 MOLECULES WITH IMPROVED GENE EDITING PROPERTIES
#2146Engineered CRISPR-Cas9 nucleases with altered PAM specificity
#2147CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
#2148ENHANCEMENT OF PREDICTABLE AND TEMPLATE-FREE GENE EDITING BY THE ASSOCIATION OF CAS WITH DNA POLYMERASE
#2149PAM RESTRICTION-FREE ADENINE BASE EDITOR FUSED PROTEIN AND USE THEREOF
#2150Antibody-conjugated nanoparticles
#2151VECTORS, SYSTEMS AND METHODS FOR EUKARYOTIC GENE EDITING
#2152Compositions of matter for detection assays
#2153Methods and compositions for genome editing in non-dividing cells
#2154DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND THERAPEUTIC APPLICATIONS
#2155SHUTTLE AGENT PEPTIDES OF MINIMAL LENGTH AND VARIANTS THEREOF ADAPTED FOR TRANSDUCTION OF CAS9-RNP AND OTHER NUCLEOPROTEIN CARGOS
#2156Cell Permeable Proteins for Genome Engineering
#2157GENOMIC EDITING OF IMPROVED EFFICIENCY AND ACCURACY
#2158COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION
#2159COMPOSITIONS COMPRISING AN RNA GUIDE TARGETING B2M AND USES THEREOF
#2160RNA-Editing Compositions and Methods of Use
#2161RNA-GUIDED ENDONUCLEASE FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#2162RNA-GUIDED ENDONUCLEASE FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#2163COMPOSITIONS AND METHODS FOR CD38 MODIFICATION
#2164PHAGE COMPOSITIONS FOR ESCHERICHIA COMPRISING CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF
#2165SELECTIVE DEGRADATION OF WILD-TYPE DNA AND ENRICHMENT OF MUTANT ALLELES USING NUCLEASE
#2166BIG-IN: A VERSATILE PLATFORM FOR LOCUS-SCALE GENOME REWRITING AND VERIFICATION
#2167COMPOSITIONS AND METHODS RELATED TO MEGAKARYOCYTE-DERIVED EXTRACELLULAR VESICLES FOR TREATING MYELOPROLIFERATIVE NEOPLASMS
#2168Controllable Transcription
#2169COMPOSITIONS AND METHODS FOR INCREASING GENOME EDITING EFFICIENCY
#2170MAMMALIAN CELLS FOR PRODUCING A SECRETED PROTEIN
#2171PROMOTING NUTRIENT ABSORPTION THROUGH THE COLON
#2172ENGINEERED CAS ENDONUCLEASE VARIANTS FOR IMPROVED GENOME EDITING
#2173MATERIALS AND METHODS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
#2174Compositions and Methods Relating to Alzheimer's Disease
#2175DUAL AAV VECTOR-MEDIATED DELETION OF LARGE MUTATIONAL HOTSPOT FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
#2176REPROGRAMMABLE ISCB NUCLEASES AND USES THEREOF
#2177MULTIPLEX GENE EDITED CELLS FOR CD70-DIRECTED CANCER IMMUNOTHERAPY
#2178CELLULAR MEMBRANE VESICLES AND USES THEREOF
#2179TYPE I CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS
#2180METHODS AND COMPOSITIONS FOR IMPROVING YIELD TRAITS
#2181NOVEL TARGETS FOR REACTIVATION OF PRADER-WILLI SYNDROME-ASSOCIATED GENES
#2182HIGH-THROUGHPUT PRECISION GENOME EDITING
#2183METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES
#2184SYSTEMS, METHODS, AND COMPOSITIONS FOR RNA-GUIDED RNA-TARGETING CRISPR EFFECTORS
#2185PHAGE ENGINEERING: PROTECTION BY CIRCULARIZED INTERMEDIATE
#2186TYPE VI CRISPR ORTHOLOGS AND SYSTEMS
#2187COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE DISEASE TYPE 1A
#2188SGRNA TARGETING AQP1 RNA, AND VECTOR AND USE THEREOF
#2189SITE SPECIFIC GENETIC ENGINEERING UTILIZING TRANS-TEMPLATE RNAS
#2190NOVEL OMNI 56, 58, 65, 68, 71, 75, 78, AND 84 CRISPR NUCLEASES
#2191NUCLEIC ACID-GUIDED NUCLEASES AND USE THEREOF
#2192ENGINEERED PROTEINS AND METHODS OF USE THEREOF
#2193CRISPR/CAS-BASED BASE EDITING COMPOSITION FOR RESTORING DYSTROPHIN FUNCTION
#2194IN VIVO ADIPOSE BIOREACTOR AND KITS FOR THE PRODUCTION AND DELIVERY OF BIOLOGIC AGENTS
#2195Lymphocyte Activation Gene 3 (LAG3) Compositions and Methods for Immunotherapy
#2196Natural Killer Cell Receptor 2B4 Compositions and Methods for Immunotherapy
#2197ALLOGENEIC THERAPEUTIC CELLS
#2198Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (CFTR) gene
#2199Blood processing apparatus and method for destroying cancer metastasis in vivo
#2200NUCLEIC ACID-BASED DATA STORAGE
#2201NUCLEIC ACID-BASED DATA STORAGE
#2202NUCLEIC ACID-BASED DATA STORAGE
#2203CATION CHELATOR HOT START
#2204RNASE H ASSISTED IN SITU ROLLING CIRCLE AMPLIFICATION
#2205HELITRON MEDIATED GENETIC MODIFICATION
#2206OPTIMIZED CRISPR-CAS DOUBLE NICKASE SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
#2207COMPOSITIONS AND METHODS FOR INHIBITING THE EXPRESSION OF MULTIPLE GENES
#2208RECONSTRUCTION OF SITE SPECIFIC NUCLEASE BINDING SITES
#2209COMPOSITIONS, SYSTEMS, AND METHODS FOR ORTHOGONAL GENOME ENGINEERING IN PLANTS
#2210CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
#2211COMPOSITION FOR CLEAVING A TARGET DNA COMPRISING A GUIDE RNA SPECIFIC FOR THE TARGET DNA AND CAS PROTEIN-ENCODING NUCLEIC ACID OR CAS PROTEIN, AND USE THEREOF
#2212COMPOSITION FOR CLEAVING A TARGET DNA COMPRISING A GUIDE RNA SPECIFIC FOR THE TARGET DNA AND CAS PROTEIN-ENCODING NUCLEIC ACID OR CAS PROTEIN, AND USE THEREOF
#2213MARF/MFN MODULATORS AND USES THEREOF
#2214COMPOSITIONS AND METHODS FOR ENHANCED NUCLEIC ACID TARGETING SPECIFICITY
#2215MEANS AND METHODS FOR MODIFYING MULTIPLE ALLELES
#2216ENGINEERED GUIDE RNA COMPRISING U-RICH TAIL FOR OPTIMIZED CRISPR/CAS12F1 SYSTEM AND USE THEREOF
#2217Gene knockout of variant NRF2 for treatment of cancer
#2218CRISPR/Cas9 MULTIPLEX KNOCKOUT OF HOST CELL PROTEINS
#2219Mammalian cell line for protein production and library generation
#2220BASE EDITING ENZYMES
#2221CAS12A NICKASES
#2222TECHNIQUE FOR MODIFYING TARGET NUCLEOTIDE SEQUENCE USING CRISPR-TYPE I-D SYSTEM
#2223MODIFIED CAS12A PROTEIN AND USE THEREOF
#2224PRIME EDITOR SYSTEM FOR IN VIVO GENOME EDITING
#2225T-Cell Immunoglobulin and Mucin Domain 3 (TIM3) Compositions and Methods for Immunotherapy
#2226DICER-LIKE KNOCK-OUT PLANT CELLS
#2227ENGINEERED T CELLS WITH REDUCED TGF-BETA RECEPTOR SIGNALING
#2228METHODS AND COMPOSITIONS FOR SEXING AND STERILIZATION IN DROSOPHILA SUZUKII AND AEDES AEGYPTI
#2229PROCESS FOR PREPARING EXTRACELLULAR VESICLES
#2230COMPOSITIONS AND METHODS OF GENOMIC MODIFICATION OF CELLS AND USES THEREOF
#2231REPLACEMENT OF RAG1 FOR USE IN THERAPY
#2232NOVEL ENHANCED BASE EDITING OR REVISING FUSION PROTEIN AND USE THEREOF
#2233COMPOSITIONS AND METHODS FOR INCREASING SHELF-LIFE OF BANANA
#2234P21 mRNA targeting DNAzymes
#2235Tracking and Manipulating Cellular RNA via Nuclear Delivery of CRISPR/CAS9
#2236COMPOSITIONS AND METHODS OF USE OF CRISPR-CAS SYSTEMS IN NUCLEOTIDE REPEAT DISORDERS
#2237Recombinogenic nucleic acid strands in situ
#2238METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION
#2239METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION
#2240Methods and Compositions Comprising Orthogonal Cytokine Responsive Immune Cells
#2241COMPOSITIONS AND METHODS FOR CD6 MODIFICATION
#2242ENGINEERED T CELLS FOR EXPRESSION OF CHIMERIC ANITGEN RECEPTORS
#2243COMPOSITIONS AND METHODS FOR TREATING RHEUMATOID ARTHRITIS
#2244METHODS AND COMPOSITIONS FOR SUPERSENSITIVE AND SPECIFIC DETECTION OF CITRUS GREENING AND PHYTOPLASMA PATHOGENS
#2245GENE CORRECTION FOR X-CGD IN HEMATOPOIETIC STEM AND PROGENITOR CELLS
#2246CONSTRUCTS, COMPOSITIONS AND METHODS THEREOF HAVING IMPROVED GENOME EDITING EFFICIENCY AND SPECIFICITY
#2247AAV-MEDIATED HOMOLOGY-INDEPENDENT TARGETED INTEGRATION GENE EDITING FOR CORRECTION OF DIVERSE DMD MUTATIONS IN PATIENTS WITH MUSCULAR DYSTROPHY
#2248PRIME EDITING TECHNOLOGY FOR PLANT GENOME ENGINEERING
#2249COMPOUNDS AND METHODS FOR REDUCING APOE EXPRESSION
#2250PRIME EDITING GUIDE RNAS, COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
#2251ACTIVATORS OF TYPE III CAS PROTEINS
#2252METHOD AND AGENT FOR TREATING/PREVENTING NEURODEGENERATIVE DISEASE AND ASSOCIATED NEUROINFLAMMATION AND FOR EVALUATING PUTATIVE PROPHYLACTICS/THERAPEUTICS FOR TREATING/PREVENTING NEURODEGENERATIVE DISEASE AND NEUROINFLAMMATION
#2253ENGINEERED CAS9 VARIANTS
#2254TCRa homing endonuclease variants
#2255PROGRAMMABLE NUCLEASES AND METHODS OF USE
#2256MEDICAL CLEANING COMPOSITION, USE AND METHOD OF CLEANING
#2257CD70+ SOLID TUMOR THERAPY USING GENETICALLY ENGINEERED T CELLS TARGETING CD70
#2258DONOR T-CELLS WITH KILL SWITCH
#2259SYSTEMS, METHODS AND COMPOSITION OF USING RNASE III MUTANTS TO PRODUCE SRNA TO CONTROL HOST PATHOGEN INFECTION
#2260STERILE ORGANISMS, METHODS OF MAKING, AND METHODS OF USE THEREOF
#2261COMPOSITIONS AND METHODS FOR ENHANCING CORN TRAITS AND YIELD USING GENOME EDITING
#2262A HIGH-THROUGHPUT SCREENING METHOD TO DISCOVER OPTIMAL GRNA PAIRS FOR CRISPR-MEDIATED EXON DELETION
#2263METHODS AND COMPOSITIONS FOR MODULATING A GENOME
#2264SCARLESS GENOME EDITING THROUGH TWO-STEP HOMOLOGY DIRECTED REPAIR
#2265Defining source of bits in trigger frame for disregard bits and releasing redundant beamformed bit
#2266METHODS AND COMPOSITIONS FOR ENHANCING YIELD AND DISEASE RESISTANCE
#2267GENE EDITING MOLECULAR CLONING KITS
#2268BOOSTING HOMOLOGY DIRECTED REPAIR IN PLANTS
#2269COMPOSITIONS AND METHODS FOR GENETIC MODIFICATION AND TARGETING
#2270TARGETING BCL11A DISTAL REGULATORY ELEMENTS FOR FETAL HEMOGLOBIN REINDUCTION
#2271NUCLEOBASE EDITORS COMPRISING NUCLEIC ACID PROGRAMMABLE DNA BINDING PROTEINS
#2272ENHANCEMENT OF SAFETY AND PRECISION FOR CRISPR-Cas INDUCED GENE EDITING BY VARIANTS OF DNA POLYMERASE USING CAS-PLUS VARIANTS
#2273BASE EDITING ENZYMES
#2274BASE EDITING ENZYMES
#2275CRISPR-MEDIATED DIRECTED CODON RE-WRITE
#2276NUCLEASE-MEDIATED NUCLEIC ACID MODIFICATION
#2277CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
#2278Targeted RNA cleavage with dCas13-RNase Fusion Proteins
#2279GENE EDITING OF SATELLITE CELLS IN VIVO USING AAV VECTORS ENCODING MUSCLE-SPECIFIC PROMOTERS
#2280MAD7 NUCLEASE IN PLANTS AND EXPANDING ITS PAM RECOGNITION CAPABILITY
#2281TRANSPOSON, GENE TRANSFER SYSTEM AND METHOD OF USING THE SAME
#2282METHODS AND COMPOSITIONS FOR OCULAR CELL THERAPY
#2283Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same
#2284DCAS13-MEDIATED THERAPEUTIC RNA BASE EDITING FOR IN VIVO GENE THERAPY
#2285TARGETED DISRUPTION OF T CELL RECEPTOR GENES USING ENGINEERED ZINC FINGER PROTEIN NUCLEASES
#2286GENETICALLY ENGINEERED T CELLS WITH DISRUPTED CASITAS B-LINEAGE LYMPHOMA PROTO-ONCOGENE-B (CBLB) AND USES THEREOF
#2287ENZYME BASED COMPOSITIONS AND METHODS FOR REMOVING DENTAL CALCULI
#2288TARGETING STROMA-CANCER INTERACTIONS IN CANCER
#2289A "LINE ELIMINATION" LATERAL FLOW IMMUNOCHROMATOGRAPHIC STRIP AND ITS APPLICATION IN CRISPR NUCLEIC ACID DETECTION
#2290Compositions of matter for detection assays
#2291DNA EDITING USING SINGLE-STRANDED DNA
#2292METHODS OF TRANSIENT PROTEIN AND GENE EXPRESSION IN CELLS
#2293COMPOSITIONS AND METHODS FOR IMPROVED SITE-SPECIFIC MODIFICATION
#2294SMALL TYPE II-D CAS PROTEINS AND METHODS OF USE THEREOF
#2295TRANSGENIC MOUSE MODELS SUPPORTING HUMAN INNATE IMMUNE FUNCTION
#2296COMPOSITIONS AND METHODS FOR ENHANCING CORN TRAITS AND YIELD USING GENOME EDITING
#2297Modifying the specificity of plant non-coding RNA molecules for silencing gene expression
#2298TOMATO GLUTAREDOXIN SlGRXC9 GENE AND ITS APPLICATION
#2299CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
#2300SYSTEMS AND METHODS FOR TRANSPOSING CARGO NUCLEOTIDE SEQUENCES
#2301Permanent Epigenetic Gene Silencing
#2302METHODS FOR USING GUIDE RNAS WITH CHEMICAL MODIFICATIONS
#2303METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES
#2304METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES
#2305Methods and compositions for prime editing nucleotide sequences
#2306Method and Reagents for Reprogramming Endothelial Cells
#2307USE OF EXONUCLEASES TO IMPROVE CRISPR/CAS-MEDIATED GENOME EDITING
#2308METHOD FOR EDITING TARGET DNA, METHOD FOR PRODUCING CELL IN WHICH TARGET DNA IS EDITED, AND DNA EDITING SYSTEM FOR USE IN THESE
#2309NOVEL RNA-GUIDED DNA NUCLEASES AND USES THEREOF
#2310GENETIC MANIPULATION METHOD IN BACTERIA
#2311SYNTHETIC MINIATURE CRISPR-CAS (CASMINI) SYSTEM FOR EUKARYOTIC GENOME ENGINEERING
#2312Constructs, compositions and methods thereof having improved genome editing efficiency and specificity
#2313MODIFIED NUCLEASES
#2314Base editing of ANGPTL3 and methods of using same for treatment of disease
#2315OPTIMIZATION OF ENGINEERED MEGANUCLEASES FOR RECOGNITION SEQUENCES
#2316Gene-regulating compositions and methods for improved immunotherapy
#2317METHODS OF GENERATING AN ACTIVATION INDUCIBLE EXPRESSION SYSTEM IN IMMUNE CELLS
#2318COMPOSITIONS AND USES OF CD45 TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
#2319SIRPalpha Inhibited Macrophages and Neutrophils and Uses Thereof
#2320NUCLEASE-MEDIATED REPEAT EXPANSION
#2321NUCLEIC ACID DETECTION USING A NUCLEASE ACTUATOR
#2322CASY PROGRAMMABLE NUCLEASES AND RNA COMPONENT SYSTEMS
#2323METHODS AND COMPOSITIONS FOR TARGETED GENETIC MODIFICATION USING PAIRED GUIDE RNAS
#2324TEMPLATE GUIDE RNA MOLECULES
#2325CONJUGATE SYSTEMS AND METHODS OF USE THEREOF
#2326NUCLEIC ACIDS ENCODING CRISPR-ASSOCIATED PROTEINS AND USES THEREOF
#2327METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES
#2328Reverse transcriptases and uses thereof
#2329CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
#2330DNase variants
#2331Composition for prime editing comprising pegRNA for editing mutation of alpha-1 antitrypsin deficiency
#2332CAS9 PROTEINS WITH ENHANCED SPECIFICITY AND USES THEREOF
#2333COMPOSITIONS COMPRISING A CAS12I2 VARIANT POLYPEPTIDE AND USES THEREOF
#2334ZBTB32 INHIBITORS AND USES THEREOF
#2335SYSTEMS, DEVICES, AND METHODS FOR CLOSED-LOOP BIOELECTRONIC CONTROL
#2336ANTI-CD83 CAR-T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION
#2337MATERIALS AND METHODS FOR TREATMENT OF FRIEDREICH ATAXIA AND OTHER RELATED DISORDERS
#2338METHODS OF TREATING AN ISCHEMIC DISEASE
#2339RNA TARGETING METHODS AND COMPOSITIONS
#2340SYSTEMS AND METHODS FOR COMPUTATIONAL DESIGN OF CRISPR GUIDE RNAS FOR STRAIN-SPECIFIC CONTROL OF MICROBIOTA CONSORTIA
#2341METHODS OF SCREENING FOR PLANT GAIN OF FUNCTION MUTATIONS AND COMPOSITIONS THEREFOR
#2342Effector proteins and methods of use
#2343CONSTRUCTS AND USES THEREOF FOR EFFICIENT AND SPECIFIC GENOME EDITING
#2344COMPOSITIONS AND METHODS FOR INCREASING HOMOLOGY-DIRECTED REPAIR
#2345METHODS AND COMPOSITIONS FOR GENOME EDITING
#2346METHODS AND PRODUCTS FOR TRANSFECTING CELLS
#2347WATER-BASED HYPOTONIC LYSIS METHOD FOR ADENO-ASSOCIATED VIRUS PURIFICATION
#2348SOYBEANS HAVING LOW TRYPSIN INHIBITOR EXPRESSION OR ACTIVITY
#2349GENETIC TOOLS FOR RECOMBINING TRANSGENES AT THE SAME LOCUS
#2350METHODS, COMPOSITIONS, AND KITS FOR INHIBITING FORMATION OF ADAPTER DIMERS
#2351MINIATURIZED CYTIDINE DEAMINASE-CONTAINING COMPLEX FOR MODIFYING DOUBLE-STRANDED DNA
#2352PROGRAMMABLE DELIVERY OF RNA-GUIDED CRISPR-CAS PROTEINS TO SUBCELLULAR ORGANELLES
#2353METHOD FOR PERFORMING GENE EDITING ON TARGET SITE IN CELL
#2354SPLIT CAS12 SYSTEMS AND METHODS OF USE THEREOF
#2355CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
#2356CASZ COMPOSITIONS AND METHODS OF USE
#2357UNIVERSAL DONOR CELLS
#2358Protein Tyrosine Phosphatase 1B Inhibited Neutrophils, Neutrophil-Dendritic Cell Hybrids and Uses Thereof
#2359COMPOSITIONS FOR USE IN TREATING AUTOSOMAL DOMINANT BEST1-RELATED RETINOPATHIES
#2360IMPROVED CYTOSINE BASE EDITING SYSTEM
#2361RNA AND DNA BASE EDITING VIA ENGINEERED ADAR
#2362LOX3 GENE MODULATION AND ARMYWORM TOLERANCE
#2363PROMOTER ELEMENTS FOR IMPROVED POLYNUCLEOTIDE EXPRESSION IN PLANTS
#2364METHODS AND COMPOSITIONS FOR INCREASING EFFICIENCY OF TARGETED GENE MODIFICATION USING OLIGONUCLEOTIDE-MEDIATED GENE REPAIR
#2365Fusion protein and use thereof in base editing
#2366SYSTEMS AND METHODS FOR IDENTIFYING CELLS THAT HAVE UNDERGONE GENOME EDITING
#2367USE OF CRISPR-CAS ENDONUCLEASES FOR PLANT GENOME ENGINEERING
#2368DIET CONTROLLED EXPRESSION OF A NUCLEIC ACID ENCODING CAS9 NUCLEASE AND USES THEREOF
#2369COMPOSITIONS AND METHODS FOR CONTROLLING BLOOD PRESSURE
#2370VARIANTS OF CAS NUCLEASE
#2371ARC-BASED CAPSIDS AND USES THEREOF
#2372COMPOSITIONS AND METHODS FOR TARGETING TUMOR ASSOCIATED TRANSCRIPTION FACTORS
#2373ENGINEERED CELLS AND METHOD FOR ENGINEERING CELLS
#2374RECOMBINANT IMMUNOTOXIN COMPRISING A RIBOTOXIN OR RNASE
#2375COMPOSITIONS FOR GENOME EDITING AND METHODS OF USE THEREOF
#2376METHOD FOR ACTIVATING EXPRESSION OF GAMMA-GLOBIN GENE, AND COMPOSITION
#2377TARGETED REPLACEMENT OF ENDOGENOUS T CELL RECEPTORS
#2378INHT26 TRANSGENIC SOYBEAN
#2379IMPROVED GENE EDITING
#2380METHODS AND PRODUCTS FOR TRANSFECTING CELLS
#2381METHODS FOR PRODUCING CLINICAL-GRADE LENTIVIRAL VECTOR
#2382GUIDE EXPRESSED AS AN EXTENSION OF AN MRNA
#2383M13 BACTERIOPHAGE WITH A HIGH CYSTEINE CONTENT AND GENETICALLY ENGINEERABLE HYDROGELS
#2384CHIMERIC POLYPEPTIDES HAVING TARGETED BINDING SPECIFICITY
#2385LENTIVIRAL-FREE CYTOSOLIC DELIVERY OF PAYLOADS VIA APTAMERS
#2386COMPOSITIONS AND METHODS OF TREATMENT OF MUSCLE DISORDERS BY TARGETING H19X-ENCODED NON-CODING RNAS
#2387Methods of Modulating Expression of Target Nucleic Acid Sequences in A Cell
#2388PYRUVATE KINASE DEFICIENCY (PKD) GENE EDITING TREATMENT METHOD
#2389OMNI-103 CRISPR nuclease
#2390COMPOSITIONS AND METHODS FOR ENGINEERING AND SELECTION OF CAR T CELLS WITH DESIRED PHENOTYPES
#2391MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY
#2392METHODS AND COMPOSITIONS FOR INDUCTION OF ANTITUMOR IMMUNITY
#2393Encoded Endonuclease Assays
#2394COMPOSITIONS AND METHODS FOR TREATING CEP290-ASSOCIATED DISEASE
#2395NUCLEIC ACID DETECTION APPARATUS AND METHOD OF DETECTING NUCLEIC ACID
#2396METHODS AND COMPOSITIONS FOR CLUSTER GENERATION BY BRIDGE AMPLIFICATION
#2397METHODS AND COMPOSITIONS FOR INTEGRATION OF A DNA CONSTRUCT
#2398SUPER-ENCHANCERS FOR RECOMBINANT GENE EXPRESSION IN CHO CELLS
#2399EFFICIENT GENOME EDITING IN PRIMARY MYELOID CELLS
#2400GENE THERAPEUTICS FOR FIBRODYSPLASIA OSSIFICANS PROGRESSIVA